Drug-induced colitis: Difference between revisions

Jump to navigation Jump to search
Line 73: Line 73:
===Gross Pathology===
===Gross Pathology===
Gross pathology findings in drug-induced colitis depends on the causative drug.
Gross pathology findings in drug-induced colitis depends on the causative drug.
*In NSAID-induced colitis is characterized by nonspecific mucosal ulcers of varying degree, with intervening areas of normal mucosa. Perforations and fibrosis may also be seen. The lesions are predominantly on the right, sparing the rectum.<ref name="pmid24339669">{{cite journal| author=Tonolini M| title=Acute nonsteroidal anti-inflammatory drug-induced colitis. | journal=J Emerg Trauma Shock | year= 2013 | volume= 6 | issue= 4 | pages= 301-3 | pmid=24339669 | doi=10.4103/0974-2700.120389 | pmc=3841543 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24339669  }} </ref><ref name="pmid3774712">{{cite journal| author=Ravi S, Keat AC, Keat EC| title=Colitis caused by non-steroidal anti-inflammatory drugs. | journal=Postgrad Med J | year= 1986 | volume= 62 | issue= 730 | pages= 773-6 | pmid=3774712 | doi= | pmc=2418853 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3774712  }} </ref><ref name="pmid24942356">{{cite journal| author=Philpott HL, Nandurkar S, Lubel J, Gibson PR| title=Drug-induced gastrointestinal disorders. | journal=Postgrad Med J | year= 2014 | volume= 90 | issue= 1065 | pages= 411-9 | pmid=24942356 | doi=10.1136/postgradmedj-2013-100316rep | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24942356  }} </ref><ref name="pmid14651719">{{cite journal| author=Price AB| title=Pathology of drug-associated gastrointestinal disease. | journal=Br J Clin Pharmacol | year= 2003 | volume= 56 | issue= 5 | pages= 477-82 | pmid=14651719 | doi= | pmc=1884388 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14651719  }} </ref>
*In NSAID-induced colitis is characterized by nonspecific mucosal ulcers of varying degree, with intervening areas of normal mucosa. Perforations and fibrosis may also be seen. The lesions are predominantly on the right, sparing the rectum.<ref name="pmid27472233">{{cite journal| author=Marginean EC| title=The Ever-Changing Landscape of Drug-Induced Injury of the Lower Gastrointestinal Tract. | journal=Arch Pathol Lab Med | year= 2016 | volume= 140 | issue= 8 | pages= 748-58 | pmid=27472233 | doi=10.5858/arpa.2015-0451-RA | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27472233  }} </ref><ref name="pmid24339669">{{cite journal| author=Tonolini M| title=Acute nonsteroidal anti-inflammatory drug-induced colitis. | journal=J Emerg Trauma Shock | year= 2013 | volume= 6 | issue= 4 | pages= 301-3 | pmid=24339669 | doi=10.4103/0974-2700.120389 | pmc=3841543 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24339669  }} </ref><ref name="pmid3774712">{{cite journal| author=Ravi S, Keat AC, Keat EC| title=Colitis caused by non-steroidal anti-inflammatory drugs. | journal=Postgrad Med J | year= 1986 | volume= 62 | issue= 730 | pages= 773-6 | pmid=3774712 | doi= | pmc=2418853 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3774712  }} </ref><ref name="pmid24942356">{{cite journal| author=Philpott HL, Nandurkar S, Lubel J, Gibson PR| title=Drug-induced gastrointestinal disorders. | journal=Postgrad Med J | year= 2014 | volume= 90 | issue= 1065 | pages= 411-9 | pmid=24942356 | doi=10.1136/postgradmedj-2013-100316rep | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24942356  }} </ref><ref name="pmid14651719">{{cite journal| author=Price AB| title=Pathology of drug-associated gastrointestinal disease. | journal=Br J Clin Pharmacol | year= 2003 | volume= 56 | issue= 5 | pages= 477-82 | pmid=14651719 | doi= | pmc=1884388 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14651719  }} </ref>


==Causes==
==Causes==

Revision as of 20:59, 7 January 2017

WikiDoc Resources for Drug-induced colitis

Articles

Most recent articles on Drug-induced colitis

Most cited articles on Drug-induced colitis

Review articles on Drug-induced colitis

Articles on Drug-induced colitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Drug-induced colitis

Images of Drug-induced colitis

Photos of Drug-induced colitis

Podcasts & MP3s on Drug-induced colitis

Videos on Drug-induced colitis

Evidence Based Medicine

Cochrane Collaboration on Drug-induced colitis

Bandolier on Drug-induced colitis

TRIP on Drug-induced colitis

Clinical Trials

Ongoing Trials on Drug-induced colitis at Clinical Trials.gov

Trial results on Drug-induced colitis

Clinical Trials on Drug-induced colitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Drug-induced colitis

NICE Guidance on Drug-induced colitis

NHS PRODIGY Guidance

FDA on Drug-induced colitis

CDC on Drug-induced colitis

Books

Books on Drug-induced colitis

News

Drug-induced colitis in the news

Be alerted to news on Drug-induced colitis

News trends on Drug-induced colitis

Commentary

Blogs on Drug-induced colitis

Definitions

Definitions of Drug-induced colitis

Patient Resources / Community

Patient resources on Drug-induced colitis

Discussion groups on Drug-induced colitis

Patient Handouts on Drug-induced colitis

Directions to Hospitals Treating Drug-induced colitis

Risk calculators and risk factors for Drug-induced colitis

Healthcare Provider Resources

Symptoms of Drug-induced colitis

Causes & Risk Factors for Drug-induced colitis

Diagnostic studies for Drug-induced colitis

Treatment of Drug-induced colitis

Continuing Medical Education (CME)

CME Programs on Drug-induced colitis

International

Drug-induced colitis en Espanol

Drug-induced colitis en Francais

Business

Drug-induced colitis in the Marketplace

Patents on Drug-induced colitis

Experimental / Informatics

List of terms related to Drug-induced colitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qasim Salau, M.B.B.S., FMCPaed [2]

Synonyms and keywords: Drug-related colitis, Drug-induced enterocolitis, Non-steroidal anti-inflammatory drug (NSAID) induced colitis; Chemotherapeutic drug-induced colitis

Overview

Historical Perspective

  • [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
  • In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
  • In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

Classification

  • There is no established classification method for drug-induced colitis. However, it may be classified based on the pathophysiology pattern, type of drug and duration of symptoms.[1][2]

Classification based on pathophysiology pattern

Based on the pathophysiology, drug-induced colitis may be classified into:

Pathophysiologic pattern of colitis Drugs
Focal active colitis NSAIDs, sodium phosphate (oral)
Eosinophilic colitis NSAIDs, carbamazepine, antiplatelet drugs, estrogen, progesteron, gold
Ischemic colitis NSAIDs, digoxin, diuretics, cocaine, ergotamine, serotonin agonists/antagonists, amphetamines, glutaraldehyde, antibiotics, chemotherapy drugs, drugs that cause constipation, laxatives, vasopressor agents, estrogen, progesteron, mycophenolic acid
Microscopic colitis NSAIDs, Protein pump inhibitors (lansoprazole), H2 receptor blockers (e.g. ranitidine), ticlopidine, simvastatin, carbamazepine, sertraline, oral penicillin
Pseudomembranous colitis Antibiotic-associated Clostridium difficile colitis (e.g. penicillins, clindamycin, cephalosporins, fluoroquinolones)
Apoptotic colitis NSAIDs, oral sodium phosphate, laxatives, chemotherapy drugs (especially anti-metabolites), and cyclosporine A
Neutropenic enterocolitis Chemotherapy drugs
Immune-mediated colitis Antibody to cytotoxic T-lymphocyte–associated antigen (CTLA4)

Classification based on type of drugs

Drug-induced colitis can be classified based on the type of drugs into:

  • Non-steroidal anti-inflammatory drugs (NSAID)-induced colitis
  • Chemotherapy drug-induced colitis
  • Antibiotic-associated Clostridium difficile colitis
  • H2 receptor blockers induced colitis

Classification based on duration of symptoms

Based on the duration of symptoms, drug-induced colitis can be classified into:

  • Acute
  • Chronic e.g. diaphragm disease (results from prolonged use of NSAIDs)

Pathophysiology

Pathogenesis

  • The pathogenesis of drug-induced colitis depends on the causative drug. The most common drugs implicated in drug-induced colitis are NSAIDs.
    • The exact mechanism by which NSAID cause colitis is not completely understood. NSAIDs can either induce new-onset colitis or exacerbate a pre-existing colitis.[3][4][5][6]
      • NSAIDs inhibit cyclooxygenase and thus prostaglandin production. Prostaglandin helps to maintain mucosal integrity. NSAIDs also impair oxidative phosphorylation, increasing risk of oxidative injury to the gut.
      • Direct damage to the intestinal mucosa is another proposed mechanism in NSAID related injury, since the rectum is often spared with colitis mainly limited to the right side of the colon.
      • Increased intestinal permeability to antigens following the use of NSAIDs is another hypothesized mechanism. This is said to cause the activation of the immune system and subsequent inflammation.

Genetics

  • There is no specific genetic cause for drug-induced colitis

Gross Pathology

Gross pathology findings in drug-induced colitis depends on the causative drug.

  • In NSAID-induced colitis is characterized by nonspecific mucosal ulcers of varying degree, with intervening areas of normal mucosa. Perforations and fibrosis may also be seen. The lesions are predominantly on the right, sparing the rectum.[1][3][4][5][6]

Causes

  • [Disease name] may be caused by either [cause1], [cause2], or [cause3].
  • [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
  • There are no established causes for [disease name].

Differentiating [disease name] from other Diseases

  • [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
  • [Differential dx1]
  • [Differential dx2]
  • [Differential dx3]

The table below lists the differential diagnosis of common causes of colitis:[7][8]

Diseases History and Symptoms Physical Examination Laboratory findings Other Findings
Diarrhea Rectal bleeding Abdominal pain Atopy Dehydration Fever Hypotension Malnutrition Blood in stool (frank or occult) Microorganism in stool Pseudomembranes on endoscopy Lab Test 4
Allergic Colitis + ++ + ++ ++
Chemical colitis + ++ ++ + + + +
Infectious colitis ++ ++ + +++ +++ ++ + ++ +
Radiation colitis + ++ + + +
Ischemic colitis + ++ ++ + ++ +

Epidemiology and Demographics

  • The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
  • In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

  • Patients of all age groups may develop [disease name].
  • [Disease name] is more commonly observed among patients aged [age range] years old.
  • [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected with [disease name] than [gender 2].
  • The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

  • There is no racial predilection for [disease name].
  • [Disease name] usually affects individuals of the [race 1] race.
  • [Race 2] individuals are less likely to develop [disease name].

Risk Factors

  • Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

  • The majority of patients with [disease name] remain asymptomatic for [duration/years].
  • Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
  • If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
  • Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
  • Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

  • The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
  • [criterion 1]
  • [criterion 2]
  • [criterion 3]
  • [criterion 4]

Symptoms

  • [Disease name] is usually asymptomatic.
  • Symptoms of [disease name] may include the following:
  • [symptom 1]
  • [symptom 2]
  • [symptom 3]
  • [symptom 4]
  • [symptom 5]
  • [symptom 6]

Physical Examination

  • Patients with [disease name] usually appear [general appearance].
  • Physical examination may be remarkable for:
  • [finding 1]
  • [finding 2]
  • [finding 3]
  • [finding 4]
  • [finding 5]
  • [finding 6]

Laboratory Findings

  • There are no specific laboratory findings associated with [disease name].
  • A [positive/negative] [test name] is diagnostic of [disease name].
  • An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
  • Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

  • There are no [imaging study] findings associated with [disease name].
  • [Imaging study 1] is the imaging modality of choice for [disease name].
  • On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
  • [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

  • [Disease name] may also be diagnosed using [diagnostic study name].
  • Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

  • There is no treatment for [disease name]; the mainstay of therapy is supportive care.
  • The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action 1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

  • Surgery is the mainstay of therapy for [disease name].
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
  • [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

  • There are no primary preventive measures available for [disease name].
  • Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
  • Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References

  1. 1.0 1.1 Marginean EC (2016). "The Ever-Changing Landscape of Drug-Induced Injury of the Lower Gastrointestinal Tract". Arch Pathol Lab Med. 140 (8): 748–58. doi:10.5858/arpa.2015-0451-RA. PMID 27472233.
  2. Odze, Robert (2015). Odze and Goldblum surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia, PA: Saunders/Elsevier. ISBN 978-1455707478.
  3. 3.0 3.1 Tonolini M (2013). "Acute nonsteroidal anti-inflammatory drug-induced colitis". J Emerg Trauma Shock. 6 (4): 301–3. doi:10.4103/0974-2700.120389. PMC 3841543. PMID 24339669.
  4. 4.0 4.1 Ravi S, Keat AC, Keat EC (1986). "Colitis caused by non-steroidal anti-inflammatory drugs". Postgrad Med J. 62 (730): 773–6. PMC 2418853. PMID 3774712.
  5. 5.0 5.1 Philpott HL, Nandurkar S, Lubel J, Gibson PR (2014). "Drug-induced gastrointestinal disorders". Postgrad Med J. 90 (1065): 411–9. doi:10.1136/postgradmedj-2013-100316rep. PMID 24942356.
  6. 6.0 6.1 Price AB (2003). "Pathology of drug-associated gastrointestinal disease". Br J Clin Pharmacol. 56 (5): 477–82. PMC 1884388. PMID 14651719.
  7. Thielman NM, Guerrant RL (2004). "Clinical practice. Acute infectious diarrhea". N Engl J Med. 350 (1): 38–47. doi:10.1056/NEJMcp031534. PMID 14702426.
  8. Khan AM, Faruque AS, Hossain MS, Sattar S, Fuchs GJ, Salam MA (2004). "Plesiomonas shigelloides-associated diarrhoea in Bangladeshi children: a hospital-based surveillance study". J Trop Pediatr. 50 (6): 354–6. doi:10.1093/tropej/50.6.354. PMID 15537721.

Template:WS Template:WH